Deutsche Bank Ag\ Oncolytics Biotech Inc Transaction History

Deutsche Bank Ag\

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$2.6 - $4.64 $19,760 - $35,264	-7,600 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$2.32 - $4.11 $17,632 - $31,236	7,600 New	7,600 $28,000
Q1 2020 May 14, 2020	SELL	$0.98 - $4.28 $492 - $2,152	-503 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$0.42 - $4.76 $5,366 - $60,818	-12,777 Reduced 96.21%	503 $2,000
Q3 2019 Nov 14, 2019	BUY	$0.54 - $1.71 $4,686 - $14,841	8,679 Added 188.63%	13,280 $7,000
Q2 2019 Aug 14, 2019	SELL	$1.63 - $1.95 $6,110 - $7,310	-3,749 Reduced 44.9%	4,601 $7,000
Q1 2019 May 15, 2019	BUY	$1.77 - $2.31 $12,478 - $16,285	7,050 Added 542.31%	8,350 $15,000
Q4 2018 Feb 14, 2019	SELL	$1.72 - $4.12 $25,284 - $60,564	-14,700 Reduced 91.88%	1,300 $2,000
Q3 2018 Dec 21, 2021	SELL	$3.83 - $5.92 $65 - $100	-17 Reduced 0.11%	16,000 $62,000
Q3 2018 Nov 14, 2018	BUY	$3.83 - $5.92 $51,004 - $78,836	13,317 Added 493.22%	16,017 $61,000
Q2 2018 Apr 21, 2020	SELL	$4.56 - $7.83 $77 - $133	-17 Reduced 0.63%	2,700 $15,000
Q2 2018 Aug 14, 2018	BUY	$4.56 - $7.83 $12,389 - $21,274	2,717 New	2,717 $14,000

1.18M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $54.4M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.